Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • loretta.manning
    Member
    • Mar 2012
    • 20

    #1

    eSeminar June 18th

    Join us for an eSeminar June 18th, Introducing the HaloPlex Next Generation Sequencing Panels Targeting Cancer and Inherited Diseases for Research

    Learn More: http://bit.ly/173qCGw

    eSeminar description: The ability to detect sequence level variations through next generation sequencing in a fast, cost effective application has revolutionized the field of genetics. In order to harness the power of next generation sequencing for specific disease states, it is critical to target these specific genomic regions. Developed in conjunction with clinical research industry leaders, Agilent Technologies offers HaloPlex next generation sequencing target enrichment panels for researching specific genetic disorders.

    Agilent’s integrated solution for clinical genomics research also includes SureCall, an easy-to-use desktop application that combines best in class open source algorithms for end-to-end NGS data analysis from alignment to categorization of mutations. With this complete workflow, customers can rapidly deploy studies for clinical research.

    eSeminar presenters: Sheila Purim, Product Manager, Agilent Technologies and Anniek De Witte, Product Manager, CGH and NGS Software, Agilent Technologies, Inc.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
72 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...